Across TCGA pan-cancer cohorts, NSA2P5 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated NSA2P5 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher NSA2P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NSA2P5 expression acts as an unfavorable survival marker, although some lineages such as ACC and LAML show a favorable association.
STAD, ACC, and UVM are the cancer types where NSA2P5 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.